Aptorum
APM | NASDAQ
$8.26
-$1.44 (-14.85%)
At close: Aug 05, 2026, 03:39 PM ET
-14.85%
(1D)Rating
Key Statistics
Market Data
Market Cap $5.24M
1D Range
8.26 9.70
52W Range
0.60 44.70
Valuation (TTM)
PE -5.16
PB 111.54
EV/EBITDA N/A
Valuation (NTM)
Forward PE N/A
Forward PEG -0.03
Price Target N/A
Cash Flow
FCF Yield -31.4%
SBC Adj. FCF Yield -31.4%
SBC Impact N/A
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
-67.0%
Dil EPS 3Y | 5Y 135.5% |
69.2%
FCF 3Y | 5Y 72.0% |
48.9%
Returns
ROA 4.1%
ROE 6.1%
ROIC 0.0%
Financial Health
Net Debt
$1.67M
Current Ratio 0.45
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and ...
Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Dec 18, 2018
Website www.aptorumgroup.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove APM